Granules India Ltd
GRANULESGranules India Ltd
GRANULES
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 32.94 | 4.14 | 0.27% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.01 | 6.09 | 0.55% |
Forecast & Ratings
Detailed Forecast from 7 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Granules India Limited is a pharmaceutical company that manufactures finished dosages (FDs), pharmaceutical formulation intermediates (PFIs) and active pharmaceutical ingredients (APIs).
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,362.41 | 1,445.21 | 1,711.45 | 2,354.63 | 2,688.44 | 3,264.42 | 3,782.53 | 4,525.70 | 4,510.77 | 4,510.77 | ||||||||||
Raw Materials | 761.96 | 679.96 | 902.90 | 1,338.97 | 1,314.92 | 1,590.28 | 2,036.42 | 2,352.65 | 2,208.22 | 3,650.38 | ||||||||||
| Power & Fuel Cost | 34.97 | 38.67 | 48.22 | 57.68 | 59.74 | 68.85 | 74.66 | 95.69 | 100.64 | |||||||||||
| Employee Cost | 117.57 | 140.19 | 165.21 | 209.82 | 259.04 | 324.29 | 366.44 | 420.35 | 550.24 | |||||||||||
| Selling & Administrative Expenses | 145.21 | 174.70 | 216.04 | 262.58 | 313.30 | 427.22 | 521.25 | 580.83 | 696.63 | |||||||||||
| Operating & Other expenses | 21.20 | 78.21 | 73.83 | 26.11 | 126.33 | -28.32 | 43.92 | 148.57 | 94.66 | |||||||||||
EBITDA | 281.50 | 333.48 | 305.25 | 459.47 | 615.11 | 882.10 | 739.84 | 927.61 | 860.38 | 860.39 | ||||||||||
| Depreciation/Amortization | 58.40 | 71.51 | 76.20 | 105.48 | 136.95 | 151.46 | 158.63 | 184.49 | 207.33 | 207.33 | ||||||||||
| PBIT | 223.10 | 261.97 | 229.05 | 353.99 | 478.16 | 730.64 | 581.21 | 743.12 | 653.05 | 653.06 | ||||||||||
| Interest & Other Items | 37.07 | 32.26 | 33.06 | 28.46 | 27.02 | 26.28 | 23.21 | 55.93 | 105.82 | 105.83 | ||||||||||
| PBT | 186.03 | 229.71 | 195.99 | 325.53 | 451.14 | 704.36 | 558.00 | 687.19 | 547.23 | 547.23 | ||||||||||
| Taxes & Other Items | 63.03 | 65.20 | 63.40 | 89.11 | 115.73 | 154.90 | 145.25 | 170.58 | 141.92 | 141.94 | ||||||||||
| Net Income | 123.00 | 164.51 | 132.59 | 236.42 | 335.41 | 549.46 | 412.75 | 516.61 | 405.31 | 405.29 | ||||||||||
| EPS | 5.84 | 7.39 | 5.50 | 9.31 | 13.19 | 21.89 | 16.65 | 21.08 | 16.73 | 16.72 | ||||||||||
| DPS | 0.65 | 0.90 | 1.00 | 1.00 | 1.00 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | ||||||||||
| Payout ratio | 0.11 | 0.12 | 0.18 | 0.11 | 0.08 | 0.07 | 0.09 | 0.07 | 0.09 | 0.09 |
Company Updates
Annual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Granules India Ltd | 32.94 | 4.14 | 0.27% |
| Sun Pharmaceutical Industries Ltd | 41.74 | 5.96 | 0.81% |
| Zydus Lifesciences Ltd | 31.44 | 5.49 | 0.25% |
| Cipla Ltd | 29.39 | 5.11 | 0.87% |
Price Comparison
Compare GRANULES with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 3.10%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Increased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has increased by 2.07%
Top 5 Mutual Funds holding Granules India Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Quant Active Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.2672% | Percentage of the fund’s portfolio invested in the stock 1.66% | Change in the portfolio weight of the stock over the last 3 months 1.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 53/94 (+6) |
Aditya Birla Sun Life Pure Value Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.9399% | Percentage of the fund’s portfolio invested in the stock 2.02% | Change in the portfolio weight of the stock over the last 3 months 0.09% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 48/83 (+1) |
Quant Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.5147% | Percentage of the fund’s portfolio invested in the stock 0.32% | Change in the portfolio weight of the stock over the last 3 months -0.65% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 44/119 (-18) |
Compare 3-month MF holding change on Screener
smallcases
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Granules India Ltd
Events
Dividend Trend
No Dividend Cuts
GRANULES has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.27%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.72 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
Cash Dividend
Ex DateEx DateJul 30, 2024
Dividend/Share
₹1.50
Ex DateEx Date
Jul 30, 2024
Past Dividends
Cash Dividend
Ex DateEx DateAug 3, 2023
Dividend/Share
₹1.50
Ex DateEx Date
Aug 3, 2023
Cash Dividend
Ex DateEx DateJul 19, 2022
Dividend/Share
₹0.75
Ex DateEx Date
Jul 19, 2022
Cash Dividend
Ex DateEx DateFeb 17, 2022
Dividend/Share
₹0.25
Ex DateEx Date
Feb 17, 2022
Cash Dividend
Ex DateEx DateNov 24, 2021
Dividend/Share
₹0.25
Ex DateEx Date
Nov 24, 2021
Cash Dividend
Ex DateEx DateAug 5, 2021
Dividend/Share
₹0.25
Ex DateEx Date
Aug 5, 2021
Granules India Ltd spurts 2.3%, up for five straight sessions
Granules India Ltd rose for a fifth straight session today. The stock is quoting at Rs 563.55, up 2.3% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 1.28% on the day, quoting at 24718.65. The Sensex is at 80971.98, up 1.16%. Granules India Ltd has added around 13.02% in last one month. Meanwhile, Nifty Pharma index of which Granules India Ltd is a constituent, has added around 10% in last one month and is currently quoting at 21105.5, up 1.71% on the day. The volume in the stock stood at 7.6 lakh shares today, compared to the daily average of 17.3 lakh shares in last one month. The benchmark August futures contract for the stock is quoting at Rs 563.25, up 2.01% on the day. Granules India Ltd is up 75.21% in last one year as compared to a 25.73% gain in NIFTY and a 43.88% gain in the Nifty Pharma index.The PE of the stock is 30.5 based on TTM earnings ending March 24.Powered by Capital Market - Live
Granules India Ltd spurts 1.69%, gains for third straight session
Granules India Ltd is up for a third straight session in a row. The stock is quoting at Rs 535.65, up 1.69% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.56% on the day, quoting at 24341.6. The Sensex is at 79865.77, down 0.7%. Granules India Ltd has risen around 9.81% in last one month. Meanwhile, Nifty Pharma index of which Granules India Ltd is a constituent, has risen around 6.84% in last one month and is currently quoting at 20755.35, up 0.55% on the day. The volume in the stock stood at 10.17 lakh shares today, compared to the daily average of 18.18 lakh shares in last one month. The benchmark July futures contract for the stock is quoting at Rs 533.8, up 1.45% on the day. Granules India Ltd is up 73.38% in last one year as compared to a 23.68% spurt in NIFTY and a 45.09% spurt in the Nifty Pharma index.The PE of the stock is 29.19 based on TTM earnings ending March 24.Powered by Capital Market - Live
Granules India Ltd soars 2.74%, Gains for third straight session
Buy Granules India; target of Rs 500: Sharekhan
Granules gets U.S. FDA nod for copy of AstraZeneca’s heartburn drug
Granules India gains on nod from Japanese, Brazilian drug regulators
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 13.88%, vs industry avg of 8.96%
Increasing Market Share
Over the last 5 years, market share increased from 1.04% to 1.23%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 11.38%, vs industry avg of 15.15%